Downloads: 0 | Views: 117
Narrative Review | Medicine | India | Volume 13 Issue 5, May 2024 | Popularity: 4.8 / 10
A Conspectus Study in Treatment of COVID-19 using Monoclonal Antibodies
R. Kavitha, Lokesh R., Pooja C.
Abstract: To prevent and/or neutralise the coronavirus in infected patients, researchers are rushing to create medicines based on antibodies. The promise for understanding disease pathophysiology was initially provided by the virus's genetic and structural resemblance to the coronavirus associated with severe acute respiratory syndrome (SARS-CoV). Reports of individual monoclonal antibodies against COVID-19 have been published by researchers. The main type of biotherapeutics used in passive immunotherapy to combat viral infection is monoclonal antibodies. In the treatment of numerous diseases, the therapeutic potential of monoclonal antibodies has long been acknowledged. Neutralising monoclonal antibodies prevent the interaction between the viral spike and the ACE 2 receptor, which is present on a variety of cell types, from causing viral infection. The creation of novel monoclonal antibodies treatments for oncology, inflammation, and rare diseases as well as infectious diseases will likely be significantly impacted using the manufacturing, control, and chemistry methodologies because they create a new standard for rapidity, safety, and clinical advantage. Additional investigation into the pathogenesis of COVID-19 may help to pinpoint the best treatment targets for the creation of targeted antivirals to combat this recently discovered disease. This brief review addressed a number of MABs, including an overview of the SARS-CoV-2 immunological response, details on the structure is the spike protein of the SARS-CoV-2 virus, a primary target of the MABs, details on the MABs' mechanisms of action, comparisons to successful vaccines, and an update on the COVID-19 clinical trials using MABs.
Keywords: Monoclonal antibodies, SARS-COV, SARS-COV-2, COVID-19 biotherapy
Edition: Volume 13 Issue 5, May 2024
Pages: 988 - 992
DOI: https://www.doi.org/10.21275/SR24515184940
Make Sure to Disable the Pop-Up Blocker of Web Browser
Downloads: 492 | Views: 852
Medicine, India, Volume 9 Issue 3, March 2020
Pages: 1 - 2Clinical Profile of Tuberculosis Patients in a Tertiary Care Hospital in Mangalore
Dr Avinash N Shetty, Dr. Don Gregory Mascarenhas, Dr Akshatha Rao Aroor
Downloads: 388 | Views: 718
Medicine, India, Volume 9 Issue 2, February 2020
Pages: 1 - 5Comparison of Thrombolysis Outcome in Early and Late Thrombolysis in Acute STEMI Patients
Dr. Uddhav Khaire, Dr. Shweta Shinde
Downloads: 284 | Views: 495
Medicine, India, Volume 9 Issue 6, June 2020
Pages: 69 - 73Use of Mefenamic Acid as a Supportive Treatment of COVID-19: A Repurposing Drug
Dr. R. P. Pareek
Downloads: 210 | Views: 368
Medicine, India, Volume 9 Issue 3, March 2020
Pages: 1327 - 1330Coronaviruses (CoVs): A Walkthrough of their Multiplication and Pathologic Process
Dr. Suman Saurabh Gupta, Dr. Juhi Kumari
Downloads: 209 | Views: 400
Medicine, India, Volume 9 Issue 3, March 2020
Pages: 826 - 828The Empirical Antibiotic Use in Bacterial Infection in General Hospital Jayanagar with Reference to ICMR Treatment Guidelines for Antimicrobial Use in Common Syndromes 2019
Yogendra Shrestha, Ramesh M Tambat, K. M. Veeranna Gowda